Eric Watsky
About Eric Watsky
Eric Watsky serves as the Global Team Leader at Rallybio, a position he has held since 2018. He has extensive experience in the pharmaceutical industry, having previously worked at Alexion Pharmaceuticals and Pfizer in various leadership roles.
Work at Rallybio
Eric Watsky has served as the Global Team Leader at Rallybio since 2018. In this role, he oversees global strategies and initiatives aimed at advancing the company's mission in the biotechnology sector. His leadership contributes to the development of innovative therapies and the management of cross-functional teams to ensure alignment with the company's objectives.
Previous Experience at Alexion Pharmaceuticals
Before joining Rallybio, Eric Watsky held the position of Vice President at Alexion Pharmaceuticals, Inc. from 2014 to 2018. During his tenure, he focused on strategic initiatives that supported the company's growth and development in the pharmaceutical industry, contributing to its reputation for delivering innovative treatments.
Career at Pfizer
Eric Watsky worked at Pfizer for a total of 18 years in various capacities. He served as Executive Director in the Specialty Care Business Unit from 2009 to 2014, where he was responsible for managing key business operations. Prior to that, he held another Executive Director position from 1996 to 2009, focusing on strategic planning and execution within the organization.
Research Fellowship at NIH
Eric Watsky began his career in biomedical research as a Research Fellow at the National Institutes of Health (NIH) in the Intramural Research Program (IRP) from 1992 to 1996. His work during this period contributed to advancements in scientific understanding and research methodologies in the field.
Education at Boston University School of Medicine
Eric Watsky earned his Doctor of Medicine (MD) degree from Boston University School of Medicine, where he studied from 1984 to 1988. This education provided him with a strong foundation in medical knowledge and practice, which he has applied throughout his career in both research and industry settings.